Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Ernest

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Urology|March 1, 1991
Hypogonadal impotence treated by transdermal testosteroneR D McClure, R Oses, M L Ernest
Cancer|October 15, 1996
A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urotheliumE J Small, L J Fippin, M L Ernest, et al.
Cancer|June 1, 1994
A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinomaE J Small, J W Frye, M J Wilkinson, et al.
Cancer|June 1, 1993
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinomaM J Wilkinson, J W Frye, E J Small, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanomaK Margolin, F R Aronson, M Sznol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanomaJ A Sparano, R I Fisher, M Sunderland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanomaM B Atkins, K R O'Boyle, J A Sosman, et al.
The Cancer Journal From Scientific American|May 1, 1997
Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group StudyJ P Dutcher, R I Fisher, G Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicityJ A Sosman, F R Aronson, M Sznol, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Urology|March 1, 1991
Hypogonadal impotence treated by transdermal testosteroneR D McClure, R Oses, M L Ernest
Cancer|October 15, 1996
A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urotheliumE J Small, L J Fippin, M L Ernest, et al.
Cancer|June 1, 1994
A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinomaE J Small, J W Frye, M J Wilkinson, et al.
Cancer|June 1, 1993
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinomaM J Wilkinson, J W Frye, E J Small, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanomaK Margolin, F R Aronson, M Sznol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanomaJ A Sparano, R I Fisher, M Sunderland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanomaM B Atkins, K R O'Boyle, J A Sosman, et al.
The Cancer Journal From Scientific American|May 1, 1997
Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group StudyJ P Dutcher, R I Fisher, G Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicityJ A Sosman, F R Aronson, M Sznol, et al.
Pageof 1